AOBCOHORT3
top of page

Athena on Boards | Cohort 3

June 2020 - October 2020

TRACEY ASHCRAFT

Sr. Director, Financial Planning & Analysis

Poseida Therapeutics Inc.

ALINE M BETANCOURT

Founder & CSO

Vitabolus Inc.

LISA BOLTON

VP Human Resources, Total Rewards

UST

CHRISTINA ENGLAND

VP Marketing, Pain Franchise

Heron Therapeutics

DR. ANITA GUPTA

Anesthesiologist | Physician Executive

FDA Advisor

MEGAN HAMREUS

Chief Growth Officer & Medical Director

Scripps Health

NITA HENDRICKSON

Head of Human Resources

BD

MICKIE HENSHALL

Sr. VP, Marketing

Ambry Genetics

BETH HOFFMAN

CEO

Origami Therapeutics

NOOSHIN HUSSAINY

CFO

Obalon Therapeutics

KOREN LILBURN

Products

Locomation.ai

STEPHANIE LIVA

Executive Director & Sr. Corporate Counsel, Alliance Management, IP, & Licensing

Calithera Biosciences

CARMEN RENE

VP Finance & Corporate Controller

SOLVD Health

SHARON SCHWAB

Global Sr. Portfolio Manager

BD

ROSE SEKULOVICH

Executive Director of Bioanalytical, Translational Biology

Arcturus Therapeutics

VANESSA SMALL

Sr. Director, Biologics

Cue Health Inc.

JENNIFER WILLIAMS

VP Market Access

Heron Therapeutics

Contact Athena CEO, Holly Smithson to secure your spot on the waitlist

for the next cohort and design your board search through Athena’s On Board Series.

Athena on Boards | Mentors

Athena on Boards Committee

bottom of page